Companies: 10,795·Total market cap: $144.5T

Passage Bio, Inc.

Passage Bio, Inc.

PASGNASDAQHealthcare● Active

$5.60

+$0.13(+2.38%)

Market Cap$17963736

P/E Ratio—

52W High$20

52W Low$3.935

Avg Volume79K

Open$5.52

Beta1.41

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Passage Bio, Inc.（PASG）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PASG · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Passage Bio, Inc. 数据

分析师预测$10 · Buy

股息不分红

分析师评级与目标价

Buy11 位分析师

Strong Buy

0

Buy

6

Hold

5

Sell

0

Strong Sell

0

12-Month Price Target

$7.00Low

$5.60Current

$10.00Avg Target上涨空间 78.57%

$15.00High

合计: 11 · 买入占比: 54.5%

根据过去 3 个月内 11 位华尔街分析师，PASG 共识评级为 Buy，12 个月平均目标价 $10.00 （较现价 $5.60 上涨空间 78.57%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Passage Bio, Inc.

$5.60+2.38%$18.0M #2

Allarity Therapeutics, Inc.

$1.58+2.53%$25.1M #3

CASI Pharmaceuticals, Inc.

$0.15+3.08%$2.3M #4

$4.53+7.73%$25.4M #5

CollPlant Biotechnologies Ltd.

$0.37+0.46%$4.5M #6

Enlivex Therapeutics Ltd.

$0.71+3.18%$17.4M

关于 Passage Bio, Inc.

CEOWilliam Chou

IPO DateFeb 28, 2020

Employees60

CountryUS

Websitepassagebio.com

Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system. Their advanced pipeline includes PBGM01, designed to tre…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Passage Bio, Inc.（PASG）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 28, 2020 在 NASDAQ 上市。截至最近交易日，PASG 股价为 $5.60，市值约为 $18.0M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Passage Bio, Inc.（PASG）股价为 $5.60，在 NASDAQ 上市，52周区间为 $3.94 – $20.00。

PASG 最新股价PASG quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议